Cargando…
Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?
BACKGROUND: The prevalence of microembolic signals (MES) during the acute phase of ischemic stroke and its influence on outcome is not well studied. The aim of our study was to determine the prevalence of MES, the different factors that are associated with the presence of MES and the association bet...
Autores principales: | Idicula, Titto T, Naess, Halvor, Thomassen, Lars |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944121/ https://www.ncbi.nlm.nih.gov/pubmed/20831778 http://dx.doi.org/10.1186/1471-2377-10-79 |
Ejemplares similares
-
Admission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study'
por: Idicula, Titto T, et al.
Publicado: (2009) -
Clinical presentation and diffusion weighted MRI of acute cerebral infarction. The Bergen Stroke Study
por: Naess, Halvor, et al.
Publicado: (2009) -
Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study
por: Logallo, Nicola, et al.
Publicado: (2011) -
A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS)
por: Nacu, Aliona, et al.
Publicado: (2015) -
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
por: Logallo, Nicola, et al.
Publicado: (2014)